The Research and Development department has a unique role in attaining both short and long term goals of Drogsan Pharmaceuticals as a research and development oriented generic pharmaceutical company.


The main purpose of R & D department is to develop equivalent pharmaceuticals needed in clinics and to present high quality, safe and affordable generic solutions, attaching paramount importance to quality in pharmaceuticals and to ensuring such quality during the design process. To this end, the R&D department develops controlled release dosage forms as well as conventional dosage forms such as tablet, capsule, sachet, syrup, mouthwash, oral suspension, oral spray, nasal spray, cream, ointment, gel and topical spray in compliance with the guidelines of International Conference on Harmonization (ICH). The R&D laboratories, including the pilot manufacturing lab, are equipped with state-of-the-art technology and the experiments are conducted in accordance with Good Manufacturing Practices (GMP). Clinical bioequivalence studies for the products developed are conducted in compliance with Good Clinical Practices (GCP) and Good Laboratory Practices (GLP)


Aiming to become an internationally renowned brand, Drogsan Pharmaceuticals also develops innovative combination preparations in its R&D department, and conducts patenting, licensing and regulatory affairs for these pharmaceuticals globally, particularly in the European Union and the United States of America, through the Business Development department.


© 2019  Drogsan Pharmaceuticals
Oğuzlar Mah. 1370. Sok. No:7 06520 Balgat / Ankara TURKEY Phone:+90(312) 287 74 50 Fax:+90(312) 287 61 15 business.development@drogsan.com.tr
The information on this site, does not substitute for the doctor or pharmacist.
> Privacy Policy    > Legal Statement